NCT04594759View on ClinicalTrials.gov

Weekly Isotretinoin Therapy Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

December 21, 2021

Study Completion Date

December 21, 2021

Conditions
Acne Vulgaris
Interventions
DRUG

Isotretinoin

Participants will be getting isotretinoin (1-1.5 mg/kg/week)

Trial Locations (1)

29403

Samantha Karline, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT04594759 - Weekly Isotretinoin Therapy Study | Biotech Hunter | Biotech Hunter